Read More Pharma Industry News Imugene’s VAXINIA trial shows promising early results for solid tumours Imugene Limited (ASX: IMU), a prominent player in the immuno-oncology field, has released an encouraging update on its… byPallavi MadhirajuNovember 6, 2023